nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—TOP2A—adrenal gland cancer	0.71	0.779	CbGaD
Mitoxantrone—ABCB1—adrenal gland cancer	0.202	0.221	CbGaD
Mitoxantrone—BTK—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—SH3KBP1—adrenal gland cancer	0.00409	0.0713	CbGpPWpGaD
Mitoxantrone—PIM1—IL3-mediated signaling events—PRKACA—adrenal gland cancer	0.00376	0.0656	CbGpPWpGaD
Mitoxantrone—PIM1—GMCSF-mediated signaling events—PRKACA—adrenal gland cancer	0.00292	0.051	CbGpPWpGaD
Mitoxantrone—PIM1—adrenal cortex—adrenal gland cancer	0.00249	0.0794	CbGeAlD
Mitoxantrone—ABCG2—Abacavir transmembrane transport—ABCB1—adrenal gland cancer	0.00246	0.0429	CbGpPWpGaD
Mitoxantrone—CYP2E1—urine—adrenal gland cancer	0.00238	0.0759	CbGeAlD
Mitoxantrone—PIM1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.00233	0.0407	CbGpPWpGaD
Mitoxantrone—BTK—pituitary gland—adrenal gland cancer	0.00232	0.0741	CbGeAlD
Mitoxantrone—PIM1—Role of Calcineurin-dependent NFAT signaling in lymphocytes—PRKACA—adrenal gland cancer	0.00216	0.0377	CbGpPWpGaD
Mitoxantrone—BTK—adrenal gland—adrenal gland cancer	0.00207	0.0662	CbGeAlD
Mitoxantrone—PIM1—cardiac atrium—adrenal gland cancer	0.00206	0.0657	CbGeAlD
Mitoxantrone—PIM1—pituitary gland—adrenal gland cancer	0.00201	0.0642	CbGeAlD
Mitoxantrone—CYP3A4—urine—adrenal gland cancer	0.00191	0.0611	CbGeAlD
Mitoxantrone—PIM1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—adrenal gland cancer	0.00186	0.0324	CbGpPWpGaD
Mitoxantrone—PIM1—adrenal gland—adrenal gland cancer	0.0018	0.0573	CbGeAlD
Mitoxantrone—PIM1—Ectoderm Differentiation—SPRY2—adrenal gland cancer	0.00146	0.0254	CbGpPWpGaD
Mitoxantrone—ABCG2—Abacavir transport and metabolism—ABCB1—adrenal gland cancer	0.00141	0.0247	CbGpPWpGaD
Mitoxantrone—SLC47A1—adrenal cortex—adrenal gland cancer	0.00133	0.0426	CbGeAlD
Mitoxantrone—TOP2A—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.00131	0.0229	CbGpPWpGaD
Mitoxantrone—PIM1—Role of Calcineurin-dependent NFAT signaling in lymphocytes—BAD—adrenal gland cancer	0.00128	0.0223	CbGpPWpGaD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.00126	0.0219	CbGpPWpGaD
Mitoxantrone—SLC47A1—gonad—adrenal gland cancer	0.0011	0.0353	CbGeAlD
Mitoxantrone—PIM1—Validated targets of C-MYC transcriptional activation—TERT—adrenal gland cancer	0.00108	0.0189	CbGpPWpGaD
Mitoxantrone—SLC47A1—pituitary gland—adrenal gland cancer	0.00108	0.0344	CbGeAlD
Mitoxantrone—TOP2A—adrenal gland—adrenal gland cancer	0.00105	0.0336	CbGeAlD
Mitoxantrone—BTK—B Cell Activation—SH3KBP1—adrenal gland cancer	0.00101	0.0176	CbGpPWpGaD
Mitoxantrone—SLC47A1—adrenal gland—adrenal gland cancer	0.000963	0.0307	CbGeAlD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.00095	0.0166	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of actin dynamics for phagocytic cup formation—CDC42—adrenal gland cancer	0.000946	0.0165	CbGpPWpGaD
Mitoxantrone—ABCC1—adrenal cortex—adrenal gland cancer	0.000879	0.0281	CbGeAlD
Mitoxantrone—CYP1B1—gonad—adrenal gland cancer	0.00081	0.0258	CbGeAlD
Mitoxantrone—CYP1B1—pituitary gland—adrenal gland cancer	0.00079	0.0252	CbGeAlD
Mitoxantrone—ABCG2—adrenal cortex—adrenal gland cancer	0.000728	0.0232	CbGeAlD
Mitoxantrone—ABCC1—cardiac atrium—adrenal gland cancer	0.000727	0.0232	CbGeAlD
Mitoxantrone—BTK—Fcgamma receptor (FCGR) dependent phagocytosis—CDC42—adrenal gland cancer	0.000714	0.0125	CbGpPWpGaD
Mitoxantrone—ABCC1—pituitary gland—adrenal gland cancer	0.00071	0.0227	CbGeAlD
Mitoxantrone—PIM1—C-MYB transcription factor network—CDKN2A—adrenal gland cancer	0.000706	0.0123	CbGpPWpGaD
Mitoxantrone—CYP1B1—adrenal gland—adrenal gland cancer	0.000706	0.0225	CbGeAlD
Mitoxantrone—PIM1—C-MYB transcription factor network—PTGS2—adrenal gland cancer	0.00066	0.0115	CbGpPWpGaD
Mitoxantrone—BTK—Kit receptor signaling pathway—BAD—adrenal gland cancer	0.000642	0.0112	CbGpPWpGaD
Mitoxantrone—ABCC1—adrenal gland—adrenal gland cancer	0.000635	0.0203	CbGeAlD
Mitoxantrone—BTK—B Cell Receptor Signaling Pathway—CDC42—adrenal gland cancer	0.000618	0.0108	CbGpPWpGaD
Mitoxantrone—ABCG2—pituitary gland—adrenal gland cancer	0.000588	0.0188	CbGeAlD
Mitoxantrone—ABCC1—ABC-family proteins mediated transport—ABCB1—adrenal gland cancer	0.000576	0.0101	CbGpPWpGaD
Mitoxantrone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000563	0.00982	CbGpPWpGaD
Mitoxantrone—CYP1B1—Endogenous sterols—POMC—adrenal gland cancer	0.000547	0.00955	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000545	0.00951	CbGpPWpGaD
Mitoxantrone—ABCC1—S1P1 pathway—PTGS2—adrenal gland cancer	0.000526	0.00918	CbGpPWpGaD
Mitoxantrone—ABCG2—adrenal gland—adrenal gland cancer	0.000525	0.0168	CbGeAlD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000507	0.00884	CbGpPWpGaD
Mitoxantrone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000498	0.00869	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—PRKACA—adrenal gland cancer	0.000479	0.00835	CbGpPWpGaD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—CTNNB1—adrenal gland cancer	0.00046	0.00802	CbGpPWpGaD
Mitoxantrone—CYP2E1—adrenal gland—adrenal gland cancer	0.000455	0.0145	CbGeAlD
Mitoxantrone—BTK—DAP12 interactions—PRKACA—adrenal gland cancer	0.00045	0.00786	CbGpPWpGaD
Mitoxantrone—PIM1—Validated targets of C-MYC transcriptional activation—TP53—adrenal gland cancer	0.000413	0.0072	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—SH3KBP1—adrenal gland cancer	0.000408	0.00711	CbGpPWpGaD
Mitoxantrone—PIM1—Ectoderm Differentiation—CTNNB1—adrenal gland cancer	0.000397	0.00693	CbGpPWpGaD
Mitoxantrone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—adrenal gland cancer	0.000396	0.00691	CbGpPWpGaD
Mitoxantrone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—adrenal gland cancer	0.000394	0.00687	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Receptor Signaling Pathway—BRAF—adrenal gland cancer	0.000393	0.00685	CbGpPWpGaD
Mitoxantrone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000381	0.00665	CbGpPWpGaD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—EGFR—adrenal gland cancer	0.000364	0.00635	CbGpPWpGaD
Mitoxantrone—ABCB1—adrenal cortex—adrenal gland cancer	0.000359	0.0115	CbGeAlD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—ABCB1—adrenal gland cancer	0.000312	0.00545	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000312	0.00545	CbGpPWpGaD
Mitoxantrone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.000308	0.00537	CbGpPWpGaD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—TP53—adrenal gland cancer	0.000306	0.00533	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000305	0.00532	CbGpPWpGaD
Mitoxantrone—ABCB1—gonad—adrenal gland cancer	0.000297	0.00949	CbGeAlD
Mitoxantrone—ABCB1—pituitary gland—adrenal gland cancer	0.00029	0.00926	CbGeAlD
Mitoxantrone—BTK—DAP12 signaling—BAD—adrenal gland cancer	0.000283	0.00494	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.000274	0.00478	CbGpPWpGaD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000269	0.0047	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000267	0.00466	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—BAD—adrenal gland cancer	0.000267	0.00465	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—BAD—adrenal gland cancer	0.000267	0.00465	CbGpPWpGaD
Mitoxantrone—ABCB1—adrenal gland—adrenal gland cancer	0.000259	0.00827	CbGeAlD
Mitoxantrone—CYP1B1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000254	0.00444	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000253	0.00441	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.000251	0.00438	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000248	0.00433	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—SH3KBP1—adrenal gland cancer	0.000247	0.00431	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—BAD—adrenal gland cancer	0.000247	0.0043	CbGpPWpGaD
Mitoxantrone—ABCC1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000243	0.00423	CbGpPWpGaD
Mitoxantrone—CYP1B1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000235	0.00409	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000219	0.00382	CbGpPWpGaD
Mitoxantrone—CYP1B1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000206	0.0036	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000201	0.00351	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.000193	0.00336	CbGpPWpGaD
Mitoxantrone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000186	0.00324	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000179	0.00313	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.000178	0.0031	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000178	0.0031	CbGpPWpGaD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000177	0.00309	CbGpPWpGaD
Mitoxantrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000177	0.00309	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—PRKACA—adrenal gland cancer	0.000175	0.00305	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	0.000169	0.00295	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—PRKACA—adrenal gland cancer	0.000168	0.00293	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000167	0.00291	CbGpPWpGaD
Mitoxantrone—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000166	0.0029	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000163	0.00285	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000163	0.00284	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00016	0.00279	CbGpPWpGaD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—adrenal gland cancer	0.000156	0.00272	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CDC42—adrenal gland cancer	0.000148	0.00259	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—EGFR—adrenal gland cancer	0.000148	0.00258	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000144	0.00252	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CDC42—adrenal gland cancer	0.000143	0.00249	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	0.000139	0.00242	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—EGFR—adrenal gland cancer	0.000139	0.00242	CbGpPWpGaD
Mitoxantrone—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000135	0.00235	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	0.000134	0.00234	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.000133	0.00233	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—EGFR—adrenal gland cancer	0.000129	0.00224	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.00012	0.00209	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—PRKACA—adrenal gland cancer	0.000119	0.00208	CbGpPWpGaD
Mitoxantrone—CYP1B1—Biological oxidations—POMC—adrenal gland cancer	0.000109	0.00191	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000109	0.0019	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000107	0.00187	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000106	0.00184	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—BAD—adrenal gland cancer	0.000104	0.00181	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000103	0.0018	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SH3KBP1—adrenal gland cancer	0.000103	0.00179	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PRKACA—adrenal gland cancer	0.000102	0.00178	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SDHB—adrenal gland cancer	0.000101	0.00177	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—BAD—adrenal gland cancer	9.95e-05	0.00174	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SDHB—adrenal gland cancer	9.79e-05	0.00171	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ZNRF3—adrenal gland cancer	9.66e-05	0.00169	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SDHB—adrenal gland cancer	8.9e-05	0.00155	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CDC42—adrenal gland cancer	8.64e-05	0.00151	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	8.5e-05	0.00148	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TERT—adrenal gland cancer	8.11e-05	0.00142	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.96e-05	0.00139	CbGpPWpGaD
Mitoxantrone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	7.7e-05	0.00134	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.7e-05	0.00134	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	7.57e-05	0.00132	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	7.15e-05	0.00125	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	7.14e-05	0.00125	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—RB1—adrenal gland cancer	7.06e-05	0.00123	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TP53—adrenal gland cancer	6.85e-05	0.0012	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CTNNB1—adrenal gland cancer	6.81e-05	0.00119	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.66e-05	0.00116	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SDHD—adrenal gland cancer	6.52e-05	0.00114	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—RRM1—adrenal gland cancer	6.52e-05	0.00114	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SDHB—adrenal gland cancer	6.39e-05	0.00112	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—RB1—adrenal gland cancer	6.32e-05	0.0011	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—RRM1—adrenal gland cancer	6.31e-05	0.0011	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SDHD—adrenal gland cancer	6.31e-05	0.0011	CbGpPWpGaD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.24e-05	0.00109	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	6.21e-05	0.00108	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	6.14e-05	0.00107	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SPRY2—adrenal gland cancer	6.05e-05	0.00106	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—BAD—adrenal gland cancer	6.03e-05	0.00105	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	6.02e-05	0.00105	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—RRM1—adrenal gland cancer	5.74e-05	0.001	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SDHD—adrenal gland cancer	5.74e-05	0.001	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—CDKN2A—adrenal gland cancer	5.55e-05	0.000969	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MEN1—adrenal gland cancer	5.55e-05	0.000968	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.4e-05	0.000942	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—EGFR—adrenal gland cancer	5.4e-05	0.000942	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	5.37e-05	0.000937	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	5.3e-05	0.000925	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—EGFR—adrenal gland cancer	5.18e-05	0.000905	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MED12—adrenal gland cancer	4.86e-05	0.000848	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SDHB—adrenal gland cancer	4.81e-05	0.00084	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MED12—adrenal gland cancer	4.7e-05	0.00082	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.35e-05	0.000758	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MED12—adrenal gland cancer	4.28e-05	0.000746	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PRKACA—adrenal gland cancer	4.23e-05	0.000739	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.2e-05	0.000733	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—RRM1—adrenal gland cancer	4.12e-05	0.000719	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SDHD—adrenal gland cancer	4.12e-05	0.000719	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CTNNB1—adrenal gland cancer	3.97e-05	0.000693	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	3.95e-05	0.000689	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.6e-05	0.000629	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDC42—adrenal gland cancer	3.59e-05	0.000627	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PRKACA—adrenal gland cancer	3.55e-05	0.000619	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	3.53e-05	0.000617	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.47e-05	0.000605	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PRKACA—adrenal gland cancer	3.43e-05	0.000599	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.35e-05	0.000585	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	3.32e-05	0.000579	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EGFR—adrenal gland cancer	3.14e-05	0.000549	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PRKACA—adrenal gland cancer	3.12e-05	0.000545	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SDHD—adrenal gland cancer	3.1e-05	0.000541	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—RRM1—adrenal gland cancer	3.1e-05	0.000541	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—adrenal gland cancer	3.09e-05	0.000539	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MED12—adrenal gland cancer	3.07e-05	0.000536	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.97e-05	0.000517	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.92e-05	0.000509	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TERT—adrenal gland cancer	2.88e-05	0.000503	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GNAS—adrenal gland cancer	2.87e-05	0.000502	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ABCB1—adrenal gland cancer	2.82e-05	0.000492	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2.8e-05	0.000488	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GNAS—adrenal gland cancer	2.78e-05	0.000485	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ABCB1—adrenal gland cancer	2.73e-05	0.000476	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GNAS—adrenal gland cancer	2.53e-05	0.000441	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—BAD—adrenal gland cancer	2.51e-05	0.000437	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ABCB1—adrenal gland cancer	2.48e-05	0.000433	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.35e-05	0.00041	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MED12—adrenal gland cancer	2.31e-05	0.000404	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—BRAF—adrenal gland cancer	2.28e-05	0.000398	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	2.24e-05	0.000391	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—POMC—adrenal gland cancer	1.94e-05	0.000338	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.91e-05	0.000333	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.91e-05	0.000333	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—POMC—adrenal gland cancer	1.87e-05	0.000327	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—adrenal gland cancer	1.84e-05	0.000322	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GNAS—adrenal gland cancer	1.82e-05	0.000317	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	1.78e-05	0.000311	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—POMC—adrenal gland cancer	1.7e-05	0.000297	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.69e-05	0.000294	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CTNNB1—adrenal gland cancer	1.65e-05	0.000288	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—adrenal gland cancer	1.54e-05	0.000269	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—adrenal gland cancer	1.49e-05	0.000261	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.42e-05	0.000249	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.37e-05	0.000239	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—adrenal gland cancer	1.36e-05	0.000237	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGFR—adrenal gland cancer	1.31e-05	0.000228	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—POMC—adrenal gland cancer	1.22e-05	0.000213	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.04e-05	0.000181	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	9.75e-06	0.00017	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—POMC—adrenal gland cancer	9.21e-06	0.000161	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	8.42e-06	0.000147	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	8.27e-06	0.000144	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—adrenal gland cancer	7.34e-06	0.000128	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—POMC—adrenal gland cancer	5.67e-06	9.9e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	4.52e-06	7.89e-05	CbGpPWpGaD
